Company profile
Phynova | Harnessing the Therapeutic Power of Plants
Phynova Group Limited is a UK company with status active founded in 2004 based in South East England.
Updated 06 Jun 2026 16:52
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
SH01 | Transaction MzUyMzA3NzY2MmFkaXF6a2N4
Published 26 May 2026 09:18
Last confirmation statement made up date
Last accounts made up date
CS01 | Transaction MzQzNDYzODg3MGFkaXF6a2N4
Published 05 Sep 2024 12:34
SH01 | Transaction MzQzNDUwMDk1MGFkaXF6a2N4
Published 05 Sep 2024 07:54
SH01 | Transaction MzQzNDQ5OTY1M2FkaXF6a2N4
Published 04 Sep 2024 14:11
SH01 | Transaction MzQzNDQ5Mzc2N2FkaXF6a2N4
Published 04 Sep 2024 13:09
Company registered at Companies House
1 Sep 2023 to 28 Feb 2026
Phynova is a UK SME applying cutting-edge technology to develop functional food ingredients using medicinal plants. Phynova has developed Reducose, a water extract of white mulberry leaves, which blocks alpha-glucosidase in the small intestine, allowing carbohydrates to pass through undigested. Clinical trials have proven that Reducose lowers blood glucos...
1 May 2014 to 31 Oct 2014
IminoNorm™, Phynova's lead candidate product, is a novel, proprietary functional food ingredient developed to help consumers to maintain normal blood sugar levels. The product is intended for use in medical foods, food and drinks and other nutritional products to reduce post-prandial blood sugar levels and lower the effective glycaemic index of foods. The...
1 Apr 2014 to 31 Mar 2016
The project combines the expertise of 4 UK partners to characterise, formulate & develop a UK supply chain for IminoNorm™, a proprietary natural ingredient that, when incorporated into foods & beverages, can address diet-related health conditions such as diabetes and obesity. IminoNorm™ is derived from mulberry leaves which have a strong traditional histo...
